ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Status : No longer recruiting

3856 studies were found. Here are studies 1 to 50.
1.No longer recruiting"Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Conditions: Tooth Loss; Periodontal Disease; Tooth decay
2.No longer recruiting(1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients who Receive Neurotoxic Therapy
Conditions: Cancer; Central Nervous System Disease; Nervous System Disease; Peripheral Nervous System Disease; Progressive Multifocal Leukoencephalopathy
3.No longer recruitingA 1-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity
4.Suspended10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Conditions: adult Hodgkin's lymphoma; adult non-Hodgkin's lymphoma
5.No longer recruiting10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Conditions: stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer; Quality of Life
6.No longer recruiting12 Week Study of Anti-Viral Effect of Oral UT-231B in Non-cirrhotic Hepatitis C Patients who have Failed Interferon-based Therapy.
Condition: Hepatitis C
7.No longer recruitingA 12-week, multicenter, safety and dose-ranging study of 3 oral doses of TCH346 in patients with Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
8.Suspended17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
9.No longer recruiting2-Methoxyestradiol (2-ME2) to Treat Solid Tumor Cancers
Conditions: Pathologic Angiogenesis; Neoplasm
10.No longer recruitingA 2-Year Study of an Investigational Drug in Obese Patients
Condition: Obesity
11.No longer recruiting3 Different Dose Levels of CCI-779 in Subjects with Active Rheumatoid Arthritis on Concomitant Methotrexate Therapy
Condition: Rheumatoid Arthritis
12.No longer recruiting3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
Condition: unspecified adult solid tumor, protocol specific
13.No longer recruiting3-AP and Cytarabine in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease
14.No longer recruiting3-AP in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific
15.No longer recruiting3-AP in Treating Patients With Advanced Prostate Cancer
Conditions: recurrent prostate cancer; stage IV prostate cancer
16.Suspended3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
17.No longer recruiting3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer
Condition: unspecified adult solid tumor, protocol specific
18.No longer recruiting4'-Iodo-4'-deoxydoxorubicin in Treating Patients With Primary Systemic Amyloidosis
Condition: primary systemic amyloidosis
19.No longer recruiting41.8 degree Centigrade whole body hyperthermia for the treatment of Rheumatoid diseases
Condition: Rheumatic Diseases
20.No longer recruiting506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
Conditions: Leukemia; Lymphoma; Multiple Myeloma
21.No longer recruiting506U78 in Treating Patients With Lymphoma
Conditions: Leukemia; Lymphoma
22.Suspended506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
Conditions: recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
23.No longer recruiting506U78 in Treating Patients With Recurrent or Refractory Cutaneous T-cell Lymphoma
Conditions: recurrent cutaneous T-cell lymphoma; recurrent mycosis fungoides/Sezary syndrome
24.No longer recruiting506U78 in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or T-cell Lymphoma
Conditions: recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult T-cell leukemia/lymphoma; angioimmunoblastic T-cell lymphoma; ...
25.No longer recruiting506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
26.No longer recruiting506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ...
27.No longer recruiting6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; Stage IV rectal cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
28.No longer recruiting6-Hydroxymethylacylfulvene in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
29.No longer recruiting6-Hydroxymethylacylfulvene in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
Conditions: Adenocarcinoma of the Lung; large cell lung cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; recurrent non-small cell lung cancer
30.No longer recruiting6-Hydroxymethylacylfulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Conditions: recurrent pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
31.No longer recruitingA 6-Month Consumer Behavior Study of a Self-Management System
Condition: Hypercholesterolemia
32.No longer recruitingABI-007 in Taxol Resistant Patients with Metastatic Breast Cancer
Conditions: Breast Neoplasms; Metastases, Neoplasm
33.No longer recruitingABT-510 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
34.No longer recruitingABT-751 in Treating Patients With Locally Recurrent or Metastatic Renal Cell (Kidney) Cancer
Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
35.No longer recruitingABX-EGF in Combination with Paclitaxel and Carboplatin for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)
Conditions: Carcinoma, Non-Small-Cell Lung Neoplasm; Neoplasm Metastasis; Lung Cancer
36.No longer recruitingAcitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Conditions: basal cell carcinoma of the skin; squamous cell carcinoma of the skin
37.No longer recruitingAcitretin in Treating Patients With Skin Disease or Skin Cancer
Conditions: actinic keratosis; stage III mycosis fungoides/Sezary syndrome; stage IV mycosis fungoides/Sezary syndrome; skin metastases; ...
38.No longer recruitingAcridine Carboxamide in Treating Patients With Advanced Non-small Cell Lung Cancer
Conditions: stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
39.No longer recruitingAcridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: recurrent adult brain tumor; adult glioblastoma multiforme
40.No longer recruitingActive Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
Conditions: Graft vs Host Disease; Multiple Myeloma
41.No longer recruitingActive Specific Immunotherapy for Follicular Lymphomas with Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
Conditions: B Cell Lymphoma; Follicular Lymphoma; Lymphoma
42.No longer recruitingAcupressure and Acustimulation Wrist Bands for the Prevention of Nausea and Vomiting Caused by Chemotherapy
Conditions: unspecified adult solid tumor, protocol specific; Quality of Life; nausea and vomiting
43.No longer recruitingAcupuncture in Cardiovascular Disease
Condition: Congestive Heart Failure
44.No longer recruitingAcupuncture in Fibromyalgia
Conditions: Fibromyalgia; Pain
45.No longer recruitingAcupuncture in the Treatment of Depression
Conditions: Depressive Disorders; Depression
46.No longer recruitingAcupuncture Needling on Connective Tissue by Ultrasound
Condition: Healthy
47.No longer recruitingAcupuncture to Improve Quality of Life in Patients With Advanced Cancer
Condition: Ovarian Cancer
48.No longer recruitingAcute Otitis Media: Adjuvant Therapy to Improve Outcome
Condition: Otitis Media
49.No longer recruitingAdding New Drugs for HIV Infected Patients Failing Current Therapy
Condition: HIV Infections
50.No longer recruitingAddition of ISIS 14803 to Therapy with Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) patients not Responding Adequately to the Two Drugs
Condition: Hepatitis C, Chronic

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act